Activity of rezafungin against Candida auris. [PDF]
Locke JB+8 more
europepmc +1 more source
Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model [PDF]
Bozó, Aliz+8 more
core +1 more source
Tolerance and heteroresistance to echinocandins in <i>Candida auris</i>: conceptual issues, clinical implications, and outstanding questions. [PDF]
Shor E, Perlin DS, Kontoyiannis DP.
europepmc +1 more source
Echinocandins - first line in invasive candidiasis: how strong is this 'strong' evidence? [PDF]
João Gonçalves-Pereira, Pedro Póvoa
openalex +1 more source
<i>In vitro</i> susceptibility profiles of invasive <i>Candida</i> bloodstream isolates to ten antifungal drugs in a southern area of China. [PDF]
Sang QY+6 more
europepmc +1 more source
Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review. [PDF]
Pais MM+4 more
europepmc +1 more source
Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting? [PDF]
Kenny, Claire+2 more
core +2 more sources
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance [PDF]
Ronen Ben‐Ami+6 more
openalex +1 more source
Trends in Antifungal Resistance Among <i>Candida</i> Species: An Eight-Year Retrospective Study in the Galveston-Houston Gulf Coast Region. [PDF]
Nguyen MD, Ren P.
europepmc +1 more source